DEP-Docetaxel: Phase I started

Starpharma began an Australian Phase I trial to evaluate IV DEP-Docetaxel every 3 weeks in about 30 patients with solid tumors. Sanofi (Euronext:SAN; NYSE:SNY, Paris, France) markets Taxotere doceta...